First human test of experimental cancer drug halted early
NCT ID NCT06488716
Summary
This early-stage study tested the safety of a new cancer drug called RO7759065, both alone and combined with an existing immunotherapy drug (atezolizumab), in patients with advanced solid tumors that could not be cured by other treatments. The main goal was to find a safe dose and understand how the body processes the drug. The study was terminated after enrolling only 12 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOUR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
British Columbia Cancer Agency
Vancouver, British Columbia, V5Z 4R2, Canada
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Clinica Universidad de Navarra-Madrid
Madrid, 28027, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2MR, Canada
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
-
Sir Mortimer B Davis Jewish General Hospital-3755 Cote Sainte-Catherine
Montreal, Quebec, H3T 1E2, Canada
-
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
-
Tennesse Oncology - NASH - SCRI - PPDS
Chattanooga, Tennessee, 37404-1130, United States
-
University of Colorado
Aurora, Colorado, 80045-2517, United States
Conditions
Explore the condition pages connected to this study.